Duke University Medical Center /ID# 267966

Durham, North Carolina 27710

0 studies enrolling now · 1 studies all time

What they study most

Metastatic Colorectal Cancer

Studies at this site

• A Study Assessing Adverse Events and Disease Activity of Intravenously (IV) Infused Telisotuzumab Adizutecan in Adult Participants With c-Met Protein Above Cutoff Level Above Refractory Metastatic Colorectal Cancer — Running, not enrolling